Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Clinical Rheumatology
|
April 23, 2014
Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease
J Gunn, J D Pauling, N J McHugh
Platelets
|
September 13, 2012
The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis
J D Pauling, V B O'Donnell, N J Mchugh
British Dental Journal
|
September 24, 2016
Orofacial manifestations of systemic sclerosis
B J Veale, R Y Jablonski, T M Frech, et al.
Microvascular Research
|
March 23, 2011
Influence of the cold challenge on the discriminatory capacity of the digital distal-dorsal difference in the thermographic assessment of Raynaud's phenomenon
J D Pauling, V Flower, J A Shipley, et al.
Rheumatology International
|
May 4, 2016
Symptoms of Raynaud's phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology
M Scolnik, B Vasta, D J Hart, et al.
Clinical Rheumatology
|
October 5, 2013
Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature
B Vasta, V Flower, C Bucciarelli-Ducci, et al.
Microvascular Research
|
July 19, 2011
Comparison of infrared thermography and laser speckle contrast imaging for the dynamic assessment of digital microvascular function
J D Pauling, J A Shipley, S Raper, et al.
BBA Clinical
|
January 6, 2017
Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease
E M McCarthy, D Moreno-Martinez, F L Wilkinson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Clinical Rheumatology
|
April 23, 2014
Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease
J Gunn, J D Pauling, N J McHugh
Platelets
|
September 13, 2012
The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis
J D Pauling, V B O'Donnell, N J Mchugh
British Dental Journal
|
September 24, 2016
Orofacial manifestations of systemic sclerosis
B J Veale, R Y Jablonski, T M Frech, et al.
Microvascular Research
|
March 23, 2011
Influence of the cold challenge on the discriminatory capacity of the digital distal-dorsal difference in the thermographic assessment of Raynaud's phenomenon
J D Pauling, V Flower, J A Shipley, et al.
Rheumatology International
|
May 4, 2016
Symptoms of Raynaud's phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology
M Scolnik, B Vasta, D J Hart, et al.
Clinical Rheumatology
|
October 5, 2013
Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature
B Vasta, V Flower, C Bucciarelli-Ducci, et al.
Microvascular Research
|
July 19, 2011
Comparison of infrared thermography and laser speckle contrast imaging for the dynamic assessment of digital microvascular function
J D Pauling, J A Shipley, S Raper, et al.
BBA Clinical
|
January 6, 2017
Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease
E M McCarthy, D Moreno-Martinez, F L Wilkinson, et al.
Page
of 1